How many insider declarations has Atlas Venture Opportunity Fund I, L.P. filed?

Atlas Venture Opportunity Fund I, L.P. has filed 2 public insider declarations with SEC (Form 4).

What is Atlas Venture Opportunity Fund I, L.P.'s role?

Atlas Venture Opportunity Fund I, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does Atlas Venture Opportunity Fund I, L.P. report trades for?

Atlas Venture Opportunity Fund I, L.P. reports trades for 2 companies, including Day One Biopharmaceuticals, Inc..

What is Atlas Venture Opportunity Fund I, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 819k€.

← Executives ★ Sign in to follow

AV

Atlas Venture Opportunity Fund I, L.P.

·SEC (Form 4)

Day One Biopharmaceuticals, Inc.Dyne Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€818,625

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Atlas Venture Opportunity Fund I, L.P.. Officer active across 2 companies, notably Day One Biopharmaceuticals, Inc.. Cumulatively, 2 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €819k. Activity tracked since 1 July 2022. The latest transaction was disclosed on 1 March 2024 (Cession). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Atlas Venture Opportunity Fund I, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Day One Biopharmaceuticals, Inc. (US)Dyne Therapeutics, Inc. (US)

申报2 总计

▼

Atlas Venture Opportunity Fund I, L.P.

高管2024年3月1日Dyne Therapeutics, Inc.

US$884,52228SEC ↗

29,435 股@ US$30.05100.0% 占其流量Common StockSEC:0001415889-24-006764:0

●

Atlas Venture Opportunity Fund I, L.P.

高管2022年7月1日Day One Biopharmaceuticals, Inc.

0SEC ↗

198,280 股0Common StockSEC:0001209191-22-041171:0

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

AV

Atlas Venture Opportunity Fund I, L.P.

·SEC (Form 4)

Day One Biopharmaceuticals, Inc.Dyne Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€818,625

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Atlas Venture Opportunity Fund I, L.P.. Officer active across 2 companies, notably Day One Biopharmaceuticals, Inc.. Cumulatively, 2 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €819k. Activity tracked since 1 July 2022. The latest transaction was disclosed on 1 March 2024 (Cession). Regulator: SEC (Form 4). The full history is free.